PTC Therapeutics PTCT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's free cash flow?
- PTC Therapeutics (PTCT) reported free cash flow of -$60.24M in Q1 2026.
- How has PTC Therapeutics's free cash flow changed year-over-year?
- PTC Therapeutics's free cash flow decreased by 106.9% year-over-year, from $868.38M to -$60.24M.
- What is the long-term trend for PTC Therapeutics's free cash flow?
- Over 3 years (2021 to 2024), PTC Therapeutics's free cash flow has grown at a -25.8% compound annual growth rate (CAGR), from -$279.55M to -$114.19M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.